NANS leads effort as more insurers deem closed-loop SCS “experimental, investigational and/or unproven”

We previously informed you about a multi-state BCBS draft policy on closed-loop SCS, which ultimately was repealed. This fall, NANS was alerted that several other insurers, including Cigna, eviCore, Excellus, Humana, and UPMC, have adopted policies calling closed-loop SCS “experimental, investigational, and/or unproven.”

The SCS Subcommittee of our Advocacy and Policy Committee developed a letter objecting to this classification and sought the support of other members of the Multisociety Pain Workgroup. In the end, 11 other medical societies signed on to the effort.

NANS has contacted the medical directors at all the named insurers to express the collective concern over this classification and requested meetings. We’ll keep you updated on our progress.